NCT03835338View on ClinicalTrials.gov

WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 1, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2024

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Pulmonary Vein Isolation

Pulmonary Vein Isolation by RF Ablation

DEVICE

LAA Isolation

LAA Isolation by RF Ablation

DEVICE

LAA Occlusion

LAA Occlusion by implantation of the WATCHMAN LAAC Device

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03835338 - WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm | Biotech Hunter | Biotech Hunter